MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells.
about
MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
MERS-CoV pathogenesis and anti ...... ived antigen-presenting cells.
@en
MERS-CoV pathogenesis and anti ...... ived antigen-presenting cells.
@nl
type
label
MERS-CoV pathogenesis and anti ...... ived antigen-presenting cells.
@en
MERS-CoV pathogenesis and anti ...... ived antigen-presenting cells.
@nl
prefLabel
MERS-CoV pathogenesis and anti ...... ived antigen-presenting cells.
@en
MERS-CoV pathogenesis and anti ...... ived antigen-presenting cells.
@nl
P2093
P2860
P1433
P1476
MERS-CoV pathogenesis and anti ...... ived antigen-presenting cells.
@en
P2093
Brit J Hart
Huanying Zhou
Julie Dyall
Laura Bollinger
Matthew Frieman
Michael R Holbrook
Robin Gross
P2860
P304
P356
10.1371/JOURNAL.PONE.0194868
P407
P577
2018-03-22T00:00:00Z